semaglutide ending Novo Nordisk's obesity-drug business has exploded in just a few years. Between 2021 and 2025, the company's sales in this segment jumped roughly tenfold: from $1.3 billion to $12.4 billion, driven largely India's generic semaglutide surge |

JAMA Cardiology 2018, 3: 363-364

There is a risk that emphasizing pharmaceutical interventions may inadvertently reinforce harmful stereotypes about obesity being solely a medical problem rather than a complex condition influenced by genetic, environmental, and social factors

Extended time above 46 degrees, or exposure to freezing, degrades the peptide

Heres what to do: Monitor symptoms closely Pay attention to any signs of severe pain, swelling, numbness, or weakness at the injection site or in the surrounding area

In a clinical trial called the STEP 2 trial, people with Type 2 diabetes and obesity lost an average of 9.6% of their body weight using semaglutide 2.4 mg, compared to just 3.4% with a placebo over 68 weeks

They work by mimicking hormones your body naturally produces after eating